Collective Audience (CAUD) Competitors $0.03 +0.00 (+6.35%) As of 07/15/2025 03:53 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock CAUD vs. SYRA, UK, DMSL, MCOM, STBX, SRAX, NHIQ, ASAP, MULN, and NHShould you be buying Collective Audience stock or one of its competitors? The main competitors of Collective Audience include Syra Health (SYRA), Ucommune International (UK), Digital Media Solutions (DMSL), Micromobility.com (MCOM), Starbox Group (STBX), SRAX (SRAX), NantHealth (NHIQ), Waitr (ASAP), Mullen Automotive (MULN), and NantHealth (NH). These companies are all part of the "business services" industry. Collective Audience vs. Its Competitors Syra Health Ucommune International Digital Media Solutions Micromobility.com Starbox Group SRAX NantHealth Waitr Mullen Automotive NantHealth Collective Audience (NASDAQ:CAUD) and Syra Health (NASDAQ:SYRA) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, media sentiment, dividends, risk and analyst recommendations. Do institutionals and insiders hold more shares of CAUD or SYRA? 60.8% of Collective Audience shares are owned by institutional investors. Comparatively, 4.8% of Syra Health shares are owned by institutional investors. 58.0% of Collective Audience shares are owned by insiders. Comparatively, 10.2% of Syra Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media refer more to CAUD or SYRA? In the previous week, Syra Health had 2 more articles in the media than Collective Audience. MarketBeat recorded 2 mentions for Syra Health and 0 mentions for Collective Audience. Collective Audience's average media sentiment score of 0.00 beat Syra Health's score of -0.46 indicating that Collective Audience is being referred to more favorably in the media. Company Overall Sentiment Collective Audience Neutral Syra Health Neutral Which has preferable earnings & valuation, CAUD or SYRA? Syra Health has lower revenue, but higher earnings than Collective Audience. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCollective Audience$12.14M0.07-$4.57MN/AN/ASyra Health$7.98M0.10-$2.94M-$0.36-0.20 Is CAUD or SYRA more profitable? Collective Audience has a net margin of 0.00% compared to Syra Health's net margin of -54.90%. Collective Audience's return on equity of 0.00% beat Syra Health's return on equity.Company Net Margins Return on Equity Return on Assets Collective AudienceN/A N/A N/A Syra Health -54.90%-131.94%-99.19% Which has more volatility & risk, CAUD or SYRA? Collective Audience has a beta of 2.93, meaning that its share price is 193% more volatile than the S&P 500. Comparatively, Syra Health has a beta of 3.86, meaning that its share price is 286% more volatile than the S&P 500. SummaryCollective Audience beats Syra Health on 7 of the 11 factors compared between the two stocks. Get Collective Audience News Delivered to You Automatically Sign up to receive the latest news and ratings for CAUD and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CAUD vs. The Competition Export to ExcelMetricCollective AudienceManagement consulting services IndustryComputer SectorNASDAQ ExchangeMarket Cap$796K$30.77M$28.01B$9.29BDividend YieldN/AN/A3.14%4.03%P/E RatioN/A7.6233.0019.58Price / Sales0.0781.241,823.9693.40Price / CashN/A25.4037.6457.93Price / BookN/A0.867.455.54Net Income-$4.57M-$7.08M$779.73M$257.73M7 Day PerformanceN/A0.67%-0.62%-0.08%1 Month PerformanceN/A-3.96%4.95%8.09%1 Year PerformanceN/A0.48%52,715.21%13.02% Collective Audience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CAUDCollective AudienceN/A$0.03+6.3%N/A-93.7%$796K$12.14M0.0023Gap UpSYRASyra Health0.147 of 5 stars$0.09-11.4%N/A-94.7%$965K$7.98M-0.1378Gap UpUKUcommune International1.1824 of 5 stars$1.06-0.7%N/A-45.3%$670K$23.92M0.00510Gap DownDMSLDigital Media SolutionsN/AN/AN/AN/A$483K$334.95M0.00580MCOMMicromobility.comN/A$0.00+4.5%N/A-72.5%$424K$13.16M0.00360Gap DownSTBXStarbox GroupN/A$1.90-18.3%N/A-99.5%$404K$6.17M0.00103High Trading VolumeSRAXSRAXN/A$0.01-81.4%N/A-91.3%$379K$29.29M0.00130Gap DownNHIQNantHealthN/A$0.01flatN/A-56.7%$359K$67M0.00340ASAPWaitrN/AN/AN/AN/A$237K$130.00M0.00840MULNMullen AutomotiveN/A$0.17-20.3%N/A-100.0%$90K$1.09M0.00120News CoverageGap UpHigh Trading VolumeNHNantHealthN/A$0.01flatN/AN/A$85K$67.68M0.00340 Related Companies and Tools Related Companies Syra Health Competitors Ucommune International Competitors Digital Media Solutions Competitors Micromobility.com Competitors Starbox Group Competitors SRAX Competitors NantHealth Competitors Waitr Competitors Mullen Automotive Competitors NantHealth Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CAUD) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collective Audience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Collective Audience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.